TABUTEAU HERRIOT

PrivateCIK: 1219927
Location

NEW YORK, NY

TABUTEAU HERRIOT (Chief Executive Officer) sold 87.3% of their position (49.66K shares) of AXSOME THERAPEUTICS, INC. on the open market

Open‑market sale worth $10.54M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 2 sales
InsiderTABUTEAU HERRIOTCIK 1219927
IssuerAXSOME THERAPEUTICS, INC.CIK 1579428
DirectorOfficer10% Owner· Chief Executive Officer
Since Feb 2026
-49.66K
Net shares
Net seller
$10.54M
Total sold
2
Open market trades
0B · 2S
6
Total transactions
49.66K acquired · 99.33K disposed
Non-Derivative Transactions4

Common Stock

Direct
M · Option Exercise

Shares

+45K

Price / share

$4.95

Trade value

$222.77K

% of position

622.5%
8/5/2026
7.23K52.23K

Common Stock

Direct
S · Sale

Shares

45K

Price / share

$212.01

Trade value

$9.54M

% of position

86.2%
8/5/2026
52.23K7.23K

Common Stock

Direct
M · Option Exercise

Shares

+4.66K

Price / share

$4.95

Trade value

$23.07K

% of position

64.5%
8/6/2026
7.23K11.89K

Common Stock

Direct
S · Sale

Shares

4.66K

Price / share

$213.95

Trade value

$997.01K

% of position

39.2%
8/6/2026
11.89K7.23K
Total

Net shares

+0.00

Net value

-$10.29M

Derivative Transactions2

Stock Option (Right to Buy)

Direct
M · Option Exercise
Converts to

Common Stock

45K shares

Shares

45K

Strike price

212.01

Held after

4.66K

Exercisable

8/5/2026

Stock Option (Right to Buy)

Direct
M · Option Exercise
Converts to

Common Stock

4.66K shares

Shares

4.66K

Strike price

213.95

Held after

0.00

Exercisable

8/6/2026
Non-Derivative Holdings (Post-Transaction)1

Common Stock

Indirect
Shares owned7.34M
Total
7.34M indirect7.34M
Derivative Holdings (Post-Transaction)0
No derivative holdings reported